iSERA Lifesciences Ltd

Fri 13/11/2026,16:1:0 | BSE : ISERA

₹143.900.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 143.90

Previous Close

₹ 143.90

Volume

70

Mkt Cap ( ₹ Cr)

₹ 121.01

High

₹ 143.90

Low

₹ 143.90

52 Week High

₹ 151.05

52 Week Low

₹ 8.96

Book Value Per Share

₹ 9.41

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on iSERA Lifesciences Ltd

Your Vote -

Buy

58.33%

Hold

33.33%

Sell

8.33%

58.33%

12 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts iSERA Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • iSERA Lifesciences - Revision In The Corporate Announcement Under Regulation 30 Made On 12/11/2026 Pursuant To The Directions

    14 Nov 2026, 7:14PM Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Adm

  • iSERA Lifesciences - Dissemination Of Warning Letter Of SEBI

    12 Nov 2026, 1:22PM Dissemination of Warning Letter of SEBI

  • iSERA Lifesciences - We Hereby Submit The Revised Un-Audited Financial Result For The Half Year Ended September 2026

    4 Nov 2026, 9:32PM We hereby submit the revised un-Audited Financial result for Half year ended September 2026 under regulation 33 of SEBI (Listing Obligations and Disc

  • iSERA Lifesciences - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati

    4 Nov 2026, 5:56PM We hereby submit that pursuant to Regulation 15(2) of SEBI (LODR) Regulations, 2015, the compliance with the corporate governance provisions as specif

  • iSERA Lifesciences - We Hereby Submit The Un-Audited Financial Result For The Quarter And Half Yearly Ended September 2026

    4 Nov 2026, 5:43PM We hereby submit the Un-Audited Financial Result for the quarter and half yearly ended September 2026

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 4Th November 2026 Under Regulation

    4 Nov 2026, 5:37PM Outcome of the Board Meeting held today on 4th November 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations

  • iSERA Lifesciences - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results Of

    31 Oct 2026, 1:33PM Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider a

  • iSERA Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    13 Oct 2026, 6:40PM We hereby submit the certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, for the quarter and half year Y ended

  • iSERA Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended October 01, 2026

    12 Oct 2026, 1:30PM As of October 2026, 55.07% is owned by Indian Promoters and 44.93% by Public. <p align=justify> Top five Promoters holding highest number of shares of

  • iSERA Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    10 Oct 2026, 10:50PM As of September 2026, 58.63% is owned by Indian Promoters and 41.37% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • iSERA Lifesciences - Announcement under Regulation 30 (LODR)-Allotment

    1 Oct 2026, 12:04PM The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As

    1 Oct 2026, 12:02PM The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2026, 4:35PM We hereby submit the proceeding of the 34th AGM

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Reg. 34 (1) Annual Report.

    5 Sep 2026, 7:30PM we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financ

  • iSERA Lifesciences - Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technolog

    5 Sep 2026, 7:14PM Notice of 34th Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, September 29, 2026 at 3:00 P.M. (IST) through video c

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of S

    1 Sep 2026, 4:05PM We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewi
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of iSERA Lifesciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 9.9099 1.5076 -0.0307 0.0088 -0.0045
Liabilities 9.9099 1.5076 -0.0307 0.0088 -0.0045
Equity 8.409 0.3234 0.3234 0.3 0
Gross Profit 0.2662 -0.1262 -0.0988 -0.1163 -0.1055
Net Profit 0.2594 0.139 -0.0988 -0.1117 -0.1055
Cash From Operating Activities -5.3542 -1.4017 -0.0606 -0.1233 -0.3
NPM(%) 19.14 0 0 0 0
Revenue 1.355 0 0 0 0
Expenses 1.0888 0.1262 0.0988 0.1163 0.1055
ROE(%) 3.27 1.75 -1.24 -1.41 -1.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to iSERA Lifesciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Prodocs Solutions Ltd 140.00 -4.76 9.48 101.45 134.14 0.00
Tata Consultancy Services Ltd 2410.00 -0.76 16.90 52091.80 13601.11 4.56
Accelya Solutions India Ltd 1017.00 1.37 15.84 214.80 639.00 8.47
Allied Digital Services Ltd 104.85 0.87 17.95 813.32 101.71 1.44

Company Info

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

Parent Organisation

iSERA Lifesciences Ltd.

Founded

27/01/1993

Managing Director

Mrs.Jayshree Suresh Jain

NSE Symbol

FAQ